OCS Heart Perfusion Post-Approval Registry

Active, not recruitingOBSERVATIONAL
Enrollment

350

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2029

Conditions
Transplant
Interventions
DEVICE

OCS Heart System

"The TransMedics® OCS Heart System is a portable system available for ex-vivo maintenance of a donor heart in a metabolically active and beating state.~The OCS Heart System's innovative technology was designed to comprehensively overcome the historical limitations of cold storage. The OCS Heart System expands the utilization of donor hearts by enabling the use of donor hearts deemed unsuitable for procurement and transplantation at initial evaluation due to limitations of cold static cardioplegic preservation."

Trial Locations (27)

10032

Nyph/Cumc, New York

10467

Montefiore, The Bronx

10595

Westchester Medical Center, Valhalla

15213

University of Pittsburgh Medical Center, Pittsburgh

27710

Duke University, Durham

30322

Emory University Hospital, Atlanta

32224

Mayo Clinic Florida, Jacksonville

33606

Tampa General Hospital, Tampa

37212

Vanderbilt University Medical Center, Nashville

40506

University of Kentucky, Lexington

48109

University of Michigan, Ann Arbor

53226

Froedtert & the Medical College of Wisconsin, Milwaukee

55407

Minneapolis Heart Institute, Minneapolis

55414

University of Minnesota, Minneapolis

55905

Mayo Clinic Rochester, Rochester

60611

Northwestern Medicine, Chicago

75226

Baylor Scott and White, Dallas

75230

Medical City Dallas, Dallas

78229

Methodist Hospital, San Antonio

90048

Cedars Sinai, Los Angeles

94143

University of California San Francisco, San Francisco

94304

Stanford University, Palo Alto

98105

University of Washington Medical Center, Seattle

06510

Yale New Haven Hospital, New Haven

02111

Tufts Medical Center, Boston

02114

Massachusetts General Hospital, Boston

02115

Brigham and Women's Hospital, Boston

Sponsors

Lead Sponsor

All Listed Sponsors
lead

TransMedics

INDUSTRY

NCT05047068 - OCS Heart Perfusion Post-Approval Registry | Biotech Hunter | Biotech Hunter